Axsome Therapeutics, Inc. (AXSM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -20.7M | -18.65M | 1.05M | -32.42M | -43.38M | -26.2M | -18.63M | -30.11M | -53.47M | -30.36M | -53.55M | -55.35M |
| Operating CF Margin % | -10.83% | -9.52% | 0.61% | -21.61% | -35.71% | -22.06% | -17.78% | -34.54% | -71.29% | -42.45% | -92.65% | -118.52% |
| Operating CF Growth % | 52.28% | 28.81% | 105.61% | -7.68% | 18.88% | 13.7% | 65.21% | 45.6% | -818.52% | -10.15% | -135.29% | -65.04% |
| Net Income | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M |
| Depreciation & Amortization | 2.37M | 2.27M | 2.41M | 1.71M | 1.72M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 1.38M |
| Stock-Based Compensation | 0 | 22.73M | 23.1M | 24.61M | 23.31M | 21.99M | 21.66M | 21.38M | 20.19M | 18.91M | 14.84M | 15.92M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -617K | 0 | 617K |
| Other Non-Cash Items | 25.03M | -8.27M | 13.98M | 3.56M | 1.16M | 11.85M | 38.32M | 2.98M | -324K | 44.83M | 1.03M | 7.13M |
| Working Capital Changes | 16.44M | -6.83M | 8.78M | -14.33M | -10.15M | 12.8M | -16.07M | 22.88M | -6.81M | 3.42M | -8.96M | -13.23M |
| Change in Receivables | -26.6M | -27.96M | 2.32M | -37.43M | -19.4M | -17.91M | -3.75M | -18.91M | -6.62M | -16.41M | -11.01M | -22.62M |
| Change in Inventory | -3.11M | -3.49M | -4.99M | -1.78M | -249K | -4.14M | 1.29M | 690K | -105K | -4.89M | 2.81M | -1.05M |
| Change in Payables | 41.16M | 11.31M | -37.4M | 5.97M | 13.66M | 7.74M | 2.91M | 7.55M | 13.11M | 11.58M | -13.86M | 7.19M |
| Cash from Investing | -121K | -71K | -58K | -13K | -338K | -30K | -90K | -52K | -98K | -7K | -371K | -133K |
| Capital Expenditures | -121K | -71K | -58K | -13K | -338K | -30K | 150K | -52K | -98K | -7K | -371K | -133K |
| CapEx % of Revenue | 0.06% | 0.04% | 0.03% | 0.01% | 0.28% | 0.03% | 0.14% | 0.06% | 0.13% | 0.01% | 0.64% | 0.28% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -240K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.99M | 16.39M | 21.27M | 34.54M | 29.27M | 14.24M | 30.41M | 14.38M | -1.19M | -2K | 33.37M | 246.08M |
| Debt Issued (Net) | -672K | -541K | -664K | -6.14M | -401K | -330K | -311K | -186K | -163K | 855K | -856K | 30M |
| Equity Issued (Net) | 16.23M | 20.91M | 25.28M | 43.78M | 19.65M | 16.42M | 13.1M | 17.78M | 2.5M | 1.15M | 33.75M | 225M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -12.56M | -3.99M | -3.35M | -3.09M | 10.02M | -1.84M | 17.61M | -3.22M | -3.52M | -2M | 476K | -8.92M |
| Net Change in Cash | -17.83M | -2.34M | 22.26M | 2.11M | -14.44M | -11.99M | 11.68M | -15.78M | -54.75M | -30.37M | -20.55M | 190.6M |
| Free Cash Flow | -20.82M | -18.72M | 988K | -32.44M | -43.71M | -26.23M | -18.48M | -30.16M | -53.56M | -30.37M | -53.92M | -55.48M |
| FCF Margin % | -10.89% | -9.55% | 0.58% | -21.62% | -35.99% | -22.09% | -17.64% | -34.6% | -71.42% | -42.46% | -93.3% | -118.81% |
| FCF Growth % | 52.37% | 28.62% | 105.35% | -7.54% | 18.39% | 13.62% | 65.72% | 45.64% | -809.11% | -9.46% | -136.24% | -64.25% |
| FCF per Share | -0.41 | -0.37 | 0.02 | -0.66 | -0.89 | -0.54 | -0.38 | -0.63 | -1.13 | -0.64 | -1.14 | -1.27 |
| FCF Conversion (FCF/Net Income) | 0.32x | 0.65x | -0.02x | 0.68x | 0.73x | 0.35x | 0.29x | 0.38x | 0.78x | 0.31x | 0.86x | 0.82x |
| Interest Paid | 0 | 3.05M | 3.22M | 3.77M | 4.59M | 4.75M | 5.02M | 5.01M | 4.9M | 4.87M | 4.73M | 3.92M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |